Invention Grant
- Patent Title: Solid forms comprising an oxime ether compound, compositions and methods of use thereof
-
Application No.: US16752041Application Date: 2020-01-24
-
Publication No.: US11629124B2Publication Date: 2023-04-18
- Inventor: Lianfeng Huang , Daozhong Zou
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D205/04
- IPC: C07D205/04 ; A61K9/20 ; A61K9/48
Abstract:
Provided herein are formulations, processes, solid forms and methods of use relating to (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic acid.
Information query
